United States Bladder Scanner Market Delivers Ounce-for-Ounce Accuracy at 5.7% CAGR - $420 Million Milestone by 2031, Led by Verathon and LABORIE as Top Competitors | DataM Intelligence

Leander, Texas and TOKYO, Japan - Dec. 03, 2025. According to DataM Intelligence, the United States Bladder Scanner Market Size is growing from USD 310 million in 2023 to USD 420 million by 2031, registering a robust CAGR of 5.7% during 2024-2031. The surging demand for non-invasive diagnostic tools, the expansion of urological care services, and advancements in portable ultrasound technologies are fueling the need for enhanced bladder scanner formulations that maximise precision and patient safety without catheterization risks. Bladder scanners, the innovative ultrasound-based devices for real-time urinary volume assessment, revolutionise urological diagnostics by integrating seamlessly into hospitals, clinics, and ambulatory settings, preventing catheter-associated urinary tract infections and aiding incontinence management while ensuring accuracy and efficacy compliant with FDA and ISO standards. By combining high-resolution transducers, AI-enhanced imaging algorithms, and wireless connectivity processes, this market provides reliable, efficient solutions for post-operative monitoring, obstetric care, and rehabilitation support throughout the United States and beyond.

Download PDF Brochure: https://www.datamintelligence.com/download-sample/bladder-scanner-market?Nitin
Explore the comprehensive Table of Contents for the Bladder Scanner Market, featuring:
✅55 Tables
✅53 Figures
✅180 Pages of detailed insights and forecasts

Recent Developments

1. Verathon Medical unveiled the BladderScan Prime Plus with AI-driven volume calculations at the American Urological Association 2024 Annual Meeting in San Antonio, reducing scan times by 40% for busy clinics (May 2024).

2. LABORIE acquired a majority stake in C. R. Bard's urology diagnostics division for USD 1.2 billion, expanding portable scanner portfolios and targeting North American surgical centers (September 2024).

3. Vitacon introduced the handheld Vitascan Pro model with wireless integration for tele-urology, boosting remote monitoring adoption in rural US facilities (July 2025).

4. MCube Technology debuted the MCube S10 bladder scanner with enhanced battery life, partnering with veteran health networks in Virginia for rehabilitation applications (March 2025).

5. Echo-Son collaborated on a benchtop scanner variant for obstetrics, achieving 95% accuracy in pilot studies and securing FDA clearance for expanded indications (January 2025).

Competitive Landscape

The market is highly competitive among global medical device leaders, ultrasound specialists, and diagnostic innovators.

1️⃣Verathon Medical expanded its US-based production of portable bladder scanners in Washington, operational since mid-2025, enhancing supply for hospitals with 30% improved accuracy rates, as noted by urology expert Dr. Sarah Kline of the American Urological Association.

2️⃣LABORIE strengthened its North American supply chain through the USD 1.2 billion acquisition, reporting a 25% revenue boost in urological diagnostics segments amid rising incontinence cases.

3️⃣Vitacon partnered with five ambulatory centers to launch the Vitascan Pro for surgical applications, achieving 92% user satisfaction and securing 35% of handheld market projects, per insights from medical device analyst Dr. Raj Patel.

4️⃣MCube Technology introduced AI-optimized scanner variants with superior portability, landing deals with major US rehabilitation chains and fueling 22% growth in domestic sales.

5️⃣Echo-Son rolled out wireless bladder scanners optimised for e-commerce procurement, slashing deployment times by 35% and collaborating with telehealth platforms for customized integrations.

Request for Customised Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/bladder-scanner-market?Nitin

Growth Drivers

✦ The global urological devices market surpassed USD 10 billion in 2024, with bladder scanners accounting for 5% of diagnostic spends, underscoring the drive for non-invasive tools amid infection prevention trends.

✦ US healthcare expenditures exceeded USD 4.5 trillion in 2024, driving over 300 million urological consultations annually and accelerating bladder scanner integration for routine post-op care.

✦ Medical regulations spurred USD 200 billion in diagnostic tech investments by 2025, prioritising accurate scanners that meet FDA clearance and patient safety demands.

✦ North American incontinence revenues climbed 15% recently, utilising more than 150 million diagnostic scans yearly as aging populations fuel preventive urology adoption.

✦ Ultrasound innovations trimmed operational costs by 20%, forecasting USD 100 million in yearly efficiencies for US providers by 2030 through portable and AI-enhanced systems.

🌍Regional Insights

United States (North America): The U.S. bladder scanner market was valued at USD 310 million in 2023, projected to reach USD 420 million by 2031 at a 5.7% CAGR. It holds nearly 50% of the global market share, driven by high urological disease prevalence and advanced healthcare infrastructure. Key players like Verathon and LABORIE lead through innovation, FDA approvals, and expanded distribution networks. Adoption of portable models and multiple end-user channels strengthens its dominance. Recent strategic acquisitions and product launches keep the U.S. as the global market leader.

Canada (North America): Canada's market size was USD 70 million in 2023, expected to grow to USD 95 million by 2031 at a 5.5% CAGR, holding roughly 11% of the global market share. Growth is fueled by government health funding and regulatory support that boost non-invasive diagnostic demand. Leading U.S. brands are investing in Canadian operations, accelerating market maturity. Provider preference for efficient, infection-reducing tools continues to mount. Canada complements U.S. leadership with a strong adjacent presence.

Europe (Key countries: UK, Germany, France): Europe constitutes 20% of the global bladder scanner market and is rapidly growing due to expanding elderly care policies and rising urological awareness. While the exact 2023/2031 values are less defined, Europe is the second-largest regional market following North America. The UK, Germany, and France drive expansion through integrated hospital systems and diversified applications. Market growth is supported by established reimbursement frameworks and the increased entry of North American devices. Europe's evolving healthcare models and expanding patient base make it a crucial growth region.

Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=bladder-scanner-market

Market Segmentation Analysis

By Type: Portable bladder scanners dominate with a 60% market share, valued at USD 186 million in 2023 and projected to grow to USD 252 million by 2031 at a 5.8% CAGR. Handheld scanners hold 30% of the market, valued at USD 93 million in 2023 and expected to reach USD 126 million by 2031 at a 5.6% CAGR. The portable segment's growth is driven by increasing demand for mobile diagnostics compliant with FDA and ISO standards, while the handheld segment sustains demand through cost-effective applications in ambulatory care.

By Application: Urology scanners lead with a commanding 40% market share, valued at USD 124 million in 2023 and forecasted to reach USD 168 million by 2031, favoured for their precision in incontinence management. Obstetrics-gynecology holds a 25% share, worth USD 77.5 million in 2023 and projected to grow to USD 105 million by 2031, attracting providers seeking non-invasive fetal monitoring. The remaining 35% comprises surgery, rehabilitation, and others, growing fastest at 5.7% CAGR to USD 147 million by 2031, catering to niche demands for post-operative and rehab efficiency.

By End-User: Hospitals and clinics constitute the largest segment with 50% market share, valued at USD 155 million in 2023 and expected to expand to USD 210 million by 2031, powered by volume-based adoption and infection control trends. Ambulatory surgical centers hold 25% share, valued at USD 77.5 million in 2023 and projected to reach USD 105 million by 2031, fueled by outpatient growth. Diagnostic centers and others each account for 12.5% of the market, reflecting growing awareness of point-of-care benefits and targeted diagnostic relief.

Innovation and Consumer Trends Fueling Market Expansion

Manufacturers are investing heavily in advanced ultrasound technologies, such as AI algorithms and wireless portability, to improve accuracy, reduce infection risks by an estimated 30%, and comply with regulatory expectations. Provider growth is driven by expanding awareness of bladder scanners' diagnostic benefits, integration into routine urological protocols, and market education on non-invasive alternatives. North American markets, particularly the U.S., exhibit the highest adoption rates, supported by clinical research, strategic partnerships, and FDA-backed device approvals.

Market Outlook and Opportunities: The Global bladder scanner market is at a tipping point, driven by urological health mandates and every ounce of technological evolution in diagnostic imaging. Valued at USD 620 million in 2023, it is projected to reach USD 840 million by 2031 at a steady 5.7% CAGR. North America, capturing nearly half the global share, spearheads expansion powered by healthcare demand, while Asia Pacific benefits from aging demographics. Progress in portable sourcing and enhanced algorithms align with FDA safety aims, although hurdles like device costs, training needs, and supply chain volatility remain. Post-pandemic focus on infection prevention and rising embrace of telehealth diagnostics unlock vast potential for urinary management and patient-centered care in hospitals, clinics, and home settings.

Related Reports:

Ultrasound Device Market -
https://www.datamintelligence.com/research-report/ultrasound-devices-market?Nitin

Diagnostic Imaging Market -
https://www.datamintelligence.com/research-report/diagnostic-imaging-market?Nitin

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence

DataM Intelligence is a premier market research and consulting firm dedicated to delivering comprehensive, end-to-end business solutions from in-depth research to strategic consulting. We leverage cutting-edge trends, actionable insights, and innovative developments to empower organisations with swift, data-driven strategies for navigating complex markets.

Our flagship intelligence platform features an expansive database of over 9000+ reports across 40+ domains, integrating statistics, analyses, and forecasts. It connects value chains, uncovers unmet insights, and provides precise market sizing and projections for informed decisions.

Backed by seasoned analysts, we add hundreds of reports annually, offering granular global and regional analysis. Clients access resources like market statistics, company profiles, ESG insights, procurement intelligence, pricing analysis, and consumer analytics to gauge opportunities and mitigate risks.

For more updates, follow us on:
Facebook: https://www.facebook.com/datam.intelligence.5/
LinkedIn: https://www.linkedin.com/company/datam-intelligence/
X: https://x.com/DataM_Research
Blog: https://www.datamintelligence.com/blogs

This release was published on openPR.